|
Market Closed -
NSE India S.E.
12:05:09 02/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 12.31 INR | +1.48% |
|
+8.65% | -36.58% |
| 08-15 | Nectar Lifesciences Limited Changes Its Corporate Office in Chandigarh | CI |
| 08-14 | Nectar Lifesciences Limited Announces Board and Committee Changes, Effective August 14, 2026 | CI |
Sales 2026 by Business Segment
Sales 2026 by Geography
Historical Breakdown of Revenue by Business Segments
Net Income: Breakdown by Business Segment
Geographical Revenue Distribution History
| Fiscal Period: March | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
Medicinal Chemicals and Botanical Products | ||||||||||
Pharmaceuticals Products | 16.69B | 15.24B | 16.85B | 16.7B | - | |||||
Total Assets | 23.91B | 21.89B | 21.91B | 20.47B | 6.22B | |||||
Interest Expense | -699M | -828M | -896M | -771M | -1.47M | |||||
Income Tax Expense | 90.34M | -182M | 133M | -479M | -305M | |||||
CAPEX | -250M | -301M | -294M | -438M | -123M | |||||
EBT | 341M | -424M | 183M | -1.62B | -879M | |||||
D&A | 570M | 591M | 607M | 624M | 228M | |||||
Net Income | 250M | -242M | 49.95M | -1.14B | -2.93B |
| Fiscal Period: March | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
India | 11.81B | 8.45B | 11.46B | 11.72B | - | |||||
Outside India | 7.45B | 9.01B | 7.79B | 7.37B | - |
- Stock Market
- Stocks
- NECLIFE Stock
- Financials Nectar Lifesciences Limited
- Business Segments
Select your edition
All financial news and data tailored to specific country editions
